011000 — Gene One Life Science Share News
0.000.00%
Last trade - 00:00Consumer CyclicalsHighly SpeculativeMicro Cap
Zika vaccine shows promise in early human trial
Zika ebbing in Latin America but vigilance needed -WHO
Brief: Gene One Life Science cancels 5.33 bln won contract with U.S. biotechnology firm
Brief: Inovio launches Zika vaccine trial
Inovio Pharma gets green signal to test Zika vaccine in human trial (updated)
Inovio Pharma gets green signal to test Zika vaccine in human trial
Brief: GeneOne Life Science signs contract with Immunomic Therapeutics
Brief: GeneOne Life Science to issue 25 bln won worth of convertible bonds
Inovio says Zika vaccine shows response in mice (updated)
Inovio says Zika vaccine shows response in mice
Interview: Zika vaccine may be ready for emergency use this year -developer (updated)
Brief: GeneOne Life Science says U.S. food and drug administration has cleared first-in-human clinical study of its collaborative vaccine for MERS
Brief: GeneOne Life, Inovio Pharma expect to move MERS vaccine into Phase I trial before year end
Inovio to start human trials of Ebola vaccine